Table 5.
Final outcome at last follow-up
| Therapy | Seizure free till last follow-up | Continued to have seizures | Ave. relapse time | Ave. recovery time ^ | Evolved to Lenox Gestaut variant* |
|---|---|---|---|---|---|
| ACTH monotherapy (n = 4) ^^ |
4 | 0 | 2 wks | 2 months | 0 |
| Vigabatrin monotherapy (n = 14) ^^ |
14 | 0 | 2 months | 1 month | 0 |
| ACTH followed by Vigabatrin (n = 14) |
1 | 13 | 6 months | 3 months | 0 |
| Vigabatrin followed by ACTH (n = 24) |
2 | 18 | 2 months | 6 months | 4 |
^ Average time to complete recovery, if occurred
^^ Remained on monotherapy till the last follow-up and didn't receive any second drug
* Evolution by 2 years